Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM)

SIMPLE SUMMARY: Immunotherapy is increasingly used in lymphoma strategy. Risk-adapted therapeutical management and set-up scores to -stratify the most vulnerable patients by risk are becoming major concerns. With the continuing upward trend of real-world data usage in addition to clinical trial data...

Descripción completa

Detalles Bibliográficos
Autores principales: Detroit, Marion, Collier, Mathis, Beeker, Nathanaël, Willems, Lise, Decroocq, Justine, Deau-Fischer, Bénédicte, Vignon, Marguerite, Birsen, Rudy, Moufle, Frederique, Leclaire, Clément, Balladur, Elisabeth, Deschamps, Paul, Chauchet, Adrien, Batista, Rui, Limat, Samuel, Treluyer, Jean-Marc, Ricard, Laure, Stocker, Nicolas, Hermine, Olivier, Choquet, Sylvain, Morel, Véronique, Metz, Carole, Bouscary, Didier, Kroemer, Marie, Zerbit, Jérémie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452259/
https://www.ncbi.nlm.nih.gov/pubmed/37627056
http://dx.doi.org/10.3390/cancers15164028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452259/
https://www.ncbi.nlm.nih.gov/pubmed/37627056
http://dx.doi.org/10.3390/cancers15164028

Ejemplares similares